Events for Pathologists

Are your transfusion guidelines up to date? Can you cope with a critical RBC or platelet shortage? This activity succinctly synthesizes current multidisciplinary transfusion practice recommendations for all blood components into a logical framework applicable to peer education, blood management programs, and electronic guidance for blood ordering. Included within this activity is a presentation of actual live participants using audience response technology to share benchmarking information on their hospital’s current practices. In addition, you will learn how they can apply up-to-date guidelines to everyday patient problems. Using this foundation, next steps to prepare for and mitigate potential blood shortages are discussed.

This activity was originally presented at CAP23 as part of the activity Can You Bank on Your Blood Supply: Using Blood Wisely and in Shortages.

Online course was released on 3/4/2024 and will end on 3/3/2027.

Direct oral anticoagulants (DOACs), such as apixaban and rivaroxaban, arrived on the market with no need for monitoring. As the use of DOACs expand, it is becoming clearer that their measurement may be necessary in specific situations, and more institutions are integrating either qualitative or quantitative assays. To help you stay abreast of current medical thought, use cases and audience polling examples are included to illustrate and prepare for new testing. Additionally, this activity addresses questions such as: Which type of assay is most appropriate for your institution? How do you validate these assays, many of which are not FDA-cleared? When should they be used? How do you integrate the testing in the ordering menu for clinicians?

This activity was originally presented at CAP23 as part of the activity Optimize or Implement Lab Testing for Xa-Inhibitory Direct Oral Anticoagulant (DOAC) Detection.